Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1554276rdf:typepubmed:Citationlld:pubmed
pubmed-article:1554276lifeskim:mentionsumls-concept:C0038895lld:lifeskim
pubmed-article:1554276lifeskim:mentionsumls-concept:C0005821lld:lifeskim
pubmed-article:1554276lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:1554276lifeskim:mentionsumls-concept:C0005767lld:lifeskim
pubmed-article:1554276lifeskim:mentionsumls-concept:C0443224lld:lifeskim
pubmed-article:1554276lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:1554276lifeskim:mentionsumls-concept:C0019116lld:lifeskim
pubmed-article:1554276lifeskim:mentionsumls-concept:C0439148lld:lifeskim
pubmed-article:1554276lifeskim:mentionsumls-concept:C2700400lld:lifeskim
pubmed-article:1554276pubmed:issue4lld:pubmed
pubmed-article:1554276pubmed:dateCreated1992-4-27lld:pubmed
pubmed-article:1554276pubmed:abstractTextTwenty units of fresh whole blood were separated into fresh packed red blood cells (PC) and platelet-rich plasma (PRP) and were transfused to 40 patients immediately after coronary bypass grafting. Patients were preoperatively randomized to receive either PRP (group A, 20 patients) or PC (group B, 20 patients). Platelet number in the PRP group was greater, but not significantly greater, than in the PC group (7.5 +/- 3 versus 5.9 +/- 2.2 x 10(10); p = not significant). However, mean platelet volume in the PC group was significantly greater (8.75 +/- 1.1 versus 6 +/- 0.7 fL). Postoperatively, group A patients bled more than group B (566 +/- 164 versus 327 +/- 41 mL; p less than 0.01) and received more red blood cell units (2.7 +/- 1.2 versus 1.6 +/- 0.7 U; p less than 0.05) and a larger number of blood products (5.9 +/- 3.7 versus 2.6 +/- 1.2 U; p less than 0.05). Transfusion of PRP to group A increased platelet count from 128 +/- 20 to 148 +/- 110 x 10(9)/L; however, platelet functions did not improve. Administration of PC to group B increased platelet count from 139 +/- 22 to 156 +/- 23 x 10(9)/L, improved platelet aggregation (with collagen from 33% +/- 20% to 53% +/- 23%, with epinephrine from 36% +/- 24% to 51% +/- 20%; p less than 0.05), and corrected the prolonged bleeding time. The results suggest that the improved hemostasis observed after fresh whole blood administration is related to the large, potent platelets that remained in the PC and were not separated to the PRP during standard platelet concentrate preparation.lld:pubmed
pubmed-article:1554276pubmed:languageenglld:pubmed
pubmed-article:1554276pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1554276pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1554276pubmed:statusMEDLINElld:pubmed
pubmed-article:1554276pubmed:monthAprlld:pubmed
pubmed-article:1554276pubmed:issn0003-4975lld:pubmed
pubmed-article:1554276pubmed:authorpubmed-author:GoorD ADAlld:pubmed
pubmed-article:1554276pubmed:authorpubmed-author:MohrRRlld:pubmed
pubmed-article:1554276pubmed:authorpubmed-author:MartinowitzUUlld:pubmed
pubmed-article:1554276pubmed:authorpubmed-author:YellinAAlld:pubmed
pubmed-article:1554276pubmed:authorpubmed-author:ShinfeldAAlld:pubmed
pubmed-article:1554276pubmed:authorpubmed-author:MoshkovitzYYlld:pubmed
pubmed-article:1554276pubmed:issnTypePrintlld:pubmed
pubmed-article:1554276pubmed:volume53lld:pubmed
pubmed-article:1554276pubmed:ownerNLMlld:pubmed
pubmed-article:1554276pubmed:authorsCompleteYlld:pubmed
pubmed-article:1554276pubmed:pagination650-4lld:pubmed
pubmed-article:1554276pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:meshHeadingpubmed-meshheading:1554276-...lld:pubmed
pubmed-article:1554276pubmed:year1992lld:pubmed
pubmed-article:1554276pubmed:articleTitleFresh blood units contain large potent platelets that improve hemostasis after open heart operations.lld:pubmed
pubmed-article:1554276pubmed:affiliationDepartment of Cardiac Surgery, Chaim Sheba Medical Center, Tel Hashomer, Israel.lld:pubmed
pubmed-article:1554276pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1554276pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1554276pubmed:publicationTypeRandomized Controlled Triallld:pubmed